echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > News! Wuwei Heavy Ion Tumor Treatment Center will be built.

    News! Wuwei Heavy Ion Tumor Treatment Center will be built.

    • Last Update: 2020-08-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    (Health Times Network reporter Huang Qixuan) a few days ago, reporters from Wuwei City, Gansu Province, the official website was informed that Wuwei heavy ion tumor treatment center in China's first independent research and development of medical heavy ion accelerator successfully out of beam (i.e., heavy ion accelerator can accelerate the desired speed of particles), which also means that China will become the world's fourth country to carry out heavy ion cancer research.
    in fact, Lanzhou heavy ion shallow treatment device as early as November 2006 has been used for the treatment of a tumor patient, the cancer patient's subcutaneous depth of about 1.5 cm of the tumor trial treatment, after 10 days of treatment, the tumor has been reduced by nearly half. In the past 10 years, 213 patients with tumor have been studied in clinical trials by the heavy ion shallow and deep heavy ion therapy device, and the overall effect has been achieved.
    " The cancer treatment center could open as early as 2016. "Staff at Wuwei Cancer Hospital in Gansu Province told The Health Times that the clinical experimental treatment of patients with heavy ion pre-tumors showed that the local control rate of heavy ion therapy was more than 80% for the most headache in lung cancer, liver cancer and even the medical community.
    heavy ion cancer treatment is a modern recognized advanced and effective radiotherapy method, accelerator radiation therapy for patients, with the health tissue radiation damage is light, short course of treatment, high cure rate and so on. According to the Gansu Morning Post, the heavy ion accelerator can run for 230 days a year (about 5,500 hours) and each heavy ion treatment center can treat 1,000 to 2,000 cancer patients a year.Zhao Hongwei, a researcher at the Institute of Modern Physics of the Chinese Academy of Sciences,
    , introduced the heavy ion cyclotron, which is designed by the Institute of Modern Physics of the Chinese Academy of Sciences and is dedicated to cancer treatment and does not have any magnetic field pad coils. The overall design starts from the consideration of reducing cost, saving energy and facilitating commercial operation, and has the characteristics of small size, few adjustable parameters and easy operation.
    it is worth mentioning that the Gansu Wuwei Heavy Ion Tumor Treatment Center, where the accelerator is located, is also the first heavy ion hospital in China. Currently, china operates only one proton center and one proton heavy ion center, located in Shandong and Shanghai. Wuwei's heavy ion tumor treatment center after the success of the beam, you can apply for CFDA testing, testing standards can be carried out clinical trials, test indicators can be officially activated after the treatment of cancer patients.
    it is understood that Wuwei heavy ion tumor treatment center started construction on May 2, 2012, with an investment of 1.6 billion yuan and 1,600 beds designed. After the center is put into use, it is estimated that the cost of treatment per patient will be less than $200,000.
    Related Reading:
    Proton Heavy Ion Therapy Indications include:
    Head and Neck Tumors:
    Nasopharyngeal Cancer, Spinal Tumor, Cartilon Sarcoma, etc.
    chest tumors:
    early and local advanced lung cancer, partial thymus cancer and chest metastatic tumors;
    abdominal tumors:
    liver cancer, pancreatic cancer, etc.
    pelvic tumors:
    prostate cancer, localresus tumors, and other limited tumors other such as pelvic tumors that cannot be surgically removed.
    the following types of diseases that are not currently suitable for treatment:
    cancer patients have multiple metastasis and end-stage patients;
    patients who are unable to stay in a recht or lying position for an extended period of time, as well as patients whose pathology has not been diagnosed, are not suitable for this treatment.
    (from Xinmin.com)
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.